- Ideanomics (NASDAQ: IDEX) announced today that Robin Mackie has been appointed Chief Operating Officer and Macy Neshati has been appointed Chief Commercial Officer, effective immediately.
Frontline plc ("Frontline") (NYSE: FRO), formerly Frontline Ltd., confirms that it has received from Euronav NV an arbitration request for proceedings on the merits following Frontline's decision to terminate the combination agreement as further explained in Frontline's press release dated 9 January 2023.
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) today announced that a study recently published in the journal Neurotherapeutics demonstrated that its lead clinical asset, ATH434, was neuroprotective in a genetic model of Parkinson's disease (PD).
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, "Biogen") announced today that an application for manufacturing and marketing approval for lecanemab (generic name, U.S.